Vaccine
EU approves Moderna’s COVID-19 vaccine
January 7, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine
The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …
Pharmafile.com’s weekly COVID-19 news round-up
January 6, 2021Research and Development COVID-19, Vaccine
In the first week of 2021, the global COVID-19 vaccination race continues to dominate the news. The EU states have …
WHO recommends against 12-week delay for COVID-19 vaccine doses
January 6, 2021Research and Development COVID-19, Vaccine, WHO
The WHO has recommended against the UK’s plans to delay second doses of the COVID-19 vaccine by 12 weeks, saying …
Israel authorises Moderna’s COVID-19 vaccine for use
January 5, 2021Manufacturing and Production COVID-19, Moderna, Vaccine
Moderna has announced that Israel’s Ministry of Health (MOH) has authorised the use of its COVID-19 vaccine. Israel has secured …
Emergex to collaborate with Bio-Manguinhos on new COVID-19 vaccine
January 5, 2021Manufacturing and Production COVID-19, Vaccine
Emergex, a company focusing on the development of medicines against viral and bacterial infectious diseases, has announced a collaboration and …
EU states to receive 100m extra doses of Pfizer-BioNTech vaccine
January 4, 2021Sales and Marketing COVID-19, EU, Pfizer, Vaccine
Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …
Concern as India approves COVID-19 vaccine before trial completion
January 4, 2021Sales and Marketing COVID-19, Vaccine
Experts have expressed concern over India’s emergency approval of its homegrown COVID-19 vaccine, Covaxin, before studies have been completed. The …
UK becomes first country to roll out Oxford University-AstraZeneca COVID-19 vaccine
January 4, 2021Sales and Marketing AstraZeneca, COVID-19, Vaccine
The UK has become the first country to administer the Oxford University-AstraZeneca COVID-19 vaccine to its population as coronavirus case …
Pharmafile.com’s weekly COVID-19 news round-up
December 23, 2020Research and Development COVID-19, Vaccine
The United States’ mission to inoculate its population is well underway this week; not only has the FDA given emergency …
Pfizer and Moderna test COVID-19 vaccines against new strain
December 22, 2020Manufacturing and Production COVID-19, Moderna, Pfizer, Vaccine
Pfizer and Moderna have begun testing their COVID-19 vaccines against the new, fast-spreading strain of the virus that was recently …
EU gives green light to Pfizer-BioNTech COVID-19 vaccine
December 22, 2020Manufacturing and Production COVID-19, EMA, Pfizer, Vaccine
The EMA has recommended the Pfizer-BioNTech COVID-19 vaccine for use across the EU’s 27 countries, with the first doses set …
Moderna’s COVID-19 vaccine receives emergency approval from FDA
December 21, 2020Sales and Marketing COVID-19, FDA, Moderna, US, Vaccine
Moderna has announced that the FDA yesterday authorised the emergency use of mRNA-1273, the biotechnology company’s vaccine against COVID-19 in …
Top Ten most popular articles on Pharmafile.com this week
December 18, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, antibody
The top news stories of the past week continue to centre around the COVID-19 pandemic; a new variant of the …
Novavax secures deal with New Zealand for 10.7m doses of COVID-19 vaccine
December 17, 2020Sales and Marketing COVID-19, Novavax, Vaccine
Novavax has announced an Advance Purchase Agreement with New Zealand for the purchase of 10.7 million doses of NVX-CoV2373, the …
FDA says Pfizer vaccine vials contain extra doses, boosting US supply
December 17, 2020Sales and Marketing COVID-19, FDA, Pfizer, Vaccine
The FDA has announced that extra doses contained in Pfizer COVID-19 vaccine vials could expand America’s supply of the jab …
Latest content
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
